The membrane-associated ubiquitin ligase MARCHF8 degrades MHC-I in HPV-positive head and neck cancer for immune evasion
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2525730123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Mohamed I Khalil und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Genetics, and Immunology, Michigan State University, East Lansing, MI 48824. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Head and Neck Neoplasms, Histocompatibility Antigens Class I, Papillomavirus Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michigan State University (MSU), NIGMS NIH HHS, NIDCR NIH HHS.
Abstract (Originalsprache)
The loss of major histocompatibility complex class I (MHC-I) molecules has been proposed as a mechanism for cancer immune evasion. Nevertheless, the mechanism is poorly understood. We report here that membrane-associated RING-CH-type finger 8 (MARCHF8), upregulated by human papillomavirus (HPV), ubiquitinates and degrades MHC-I in HPV-positive head and neck cancer (HPV+ HNC). Inhibiting MARCHF8 restores MHC-I levels on HPV+ HNC cells, suppresses tumor growth, and increases the infiltration of natural killer (NK) and T cells in the tumor microenvironment. Furthermore, Marchf8 knockout markedly increases cross talk between cytotoxic NK cells and CD8 + T cells with macrophages and enhances the tumor-killing activity of CD8 + T cells. Interestingly, Marchf8 knockout, in combination with anti-PD-1 treatment, further enhances tumor suppression and increases NK and T cell infiltration in mice bearing immune checkpoint inhibitor–refractory tumors. Our findings suggest that MARCHF8 could be a promising target for immunotherapy for HPV+ HNC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Genetics, and Immunology, Michigan State University, East Lansing, MI 48824.
- Department of Molecular Biology, National Research Centre, Cairo 12622, Egypt.
- Center for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health, Detroit, MI 48202.
- Immunology Research Program, Henry Ford Cancer Institute, Henry Ford Health, Detroit, MI 48202.
- Department of Medicine, Michigan State University, East Lansing, MI 48824.
- Henry Ford Health + Michigan State University Health Sciences, East Lansing, MI 48824.
ORCID-Profile: Mohamed I Khalil, Lexi Vu, Congcong Yin, Craig C Welbon, Kyle J Roux, Matthew P Bernard, Qing-Sheng Mi, Dohun Pyeon
Förderung
- Michigan State University (MSU)
- NIGMS NIH HHS
- NIDCR NIH HHS
- Henry Ford + Michigan State University Health Sciences
- HHS | NIH
Zitieren
APA
Khalil, M. I., Wang, J., Vu, L., Yang, C., Yin, C., Chadha, S., Nabors, H., Vocelle, D., May, D. G., Chrisopulos, R. J., Welbon, C. C., Zhou, L., Roux, K. J., Spanos, W. C., Bernard, M. P., Mi, Q. S., & Pyeon, D. (2026). The membrane-associated ubiquitin ligase MARCHF8 degrades MHC-I in HPV-positive head and neck cancer for immune evasion. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2525730123
Vancouver
Khalil MI, Wang J, Vu L, Yang C, Yin C, Chadha S, et al. The membrane-associated ubiquitin ligase MARCHF8 degrades MHC-I in HPV-positive head and neck cancer for immune evasion. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2525730123
BibTeX
@article{Khalil2026,
author = {Khalil, Mohamed I and Wang, Jie and Vu, Lexi and Yang, Canchai and Yin, Congcong and Chadha, Smriti and Nabors, Harrison and Vocelle, Daniel and May, Danielle G and Chrisopulos, Rachel J and Welbon, Craig C and Zhou, Li and Roux, Kyle J and Spanos, William C and Bernard, Matthew P and Mi, Qing-Sheng and Pyeon, Dohun},
title = {The membrane-associated ubiquitin ligase MARCHF8 degrades MHC-I in HPV-positive head and neck cancer for immune evasion},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2525730123}
}
EUVIMED